Concourse Financial Group Securities, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
28 transactions
Others Institutions Holding AMPH
# of Institutions
263Shares Held
33.2MCall Options Held
18.3KPut Options Held
13K-
Black Rock Inc. New York, NY5.94MShares$143 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$63.2 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$48.9 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$39.1 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$37.9 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.18B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...